Minnesota Ovarian Cancer Alliance Inc
Minnesota Ovarian Cancer Alliance Inc
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for Minnesota Ovarian Cancer Alliance Inc? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
The mission of the Minnesota Ovarian Cancer Alliance is to: Create an awareness regarding early warning signs that may be indicative of ovarian cancer. Create and promote resources for support, networking and education for women diagnosed with ovarian cancer and their families. Unite and educate individuals, the medical community and organizations to achieve earlier diagnosis, better treatment and a cure for ovarian cancer. Advance ovarian cancer research toward earlier diagnosis, better treatment, and a cure.
About
RESEARCH GRANTS FUNDED: MOCA IS A LEADER IN PRIVATE NONPROFIT FUNDING FOR OVARIAN CANCER RESEARCH. WE MANAGE A COMPETITIVE GRANT MAKING PROCESS EACH YEAR TO SELECT THE MOST IMPACTFUL PROJECTS TO FUND. RESEARCH PROPOSALS ARE REVIEWED BY BOTH NATIONAL SCIENTIFIC REVIEWERS WHO ARE EXPERTS IN THEIR FIELD AS WELL AS CONSUMER REVIEWERS WHO UNDERSTAND THE URGENCY OF FUNDING THAT WILL MAKE A DIFFERENCE TO THE PATIENT COMMUNITY. IN 2018, MOCA PROVIDED A TOTAL OF $775,000 TO OVARIAN CANCER RESEARCHERS. WE AWARDED $675,000 TO FIVE OVARIAN CANCER RESEARCH PROJECTS DEVELOPED BY MINNESOTA RESEARCHERS. TWO OF THE 2018 AWARDS WERE MULTI-YEAR GRANTS. WE ALSO CONTINUED FUNDING NATIONALLY IN THE AREA OF EARLY DETECTION AWARDING TWO $50,000 GRANTS TO NATIONAL RESEARCHERS WORKING IN THIS AREA. IN ADDITION, MOCA MET ITS FINAL COMMITMENT TO THE NATIONAL STAND UP TO CANCER OVARIAN CANCER DREAM TEAM AND RELEASED THE LAST $25,000 OF ITS $100,000 PLEDGED SUPPORT.MARTINA BAZZARO, PH.D. OF THE UNIVERSITY OF MINNESOTA "TARGETING OF MITOCHONDRIAL ACTIVITY TO PREVENT AND TREAT RECURRENT OVARIAN CANCER". $75,000 FOR ONE YEAR.CAROL LANGE, PH.D. & LAURA MAURO, PH.D. OF THE UNIVERSITY OF MINNESOTA "TARGETING DNA DAMAGE SENSING PROTEIN KINASES IN HEREDITARY OVARIAN CANCER. $200,000 OVER TWO YEARSSWAYAM PRABHA, PH.D. MBA OF THE UNIVERSITY OF MINNESOTA "GLYCOENGINEERED MESENCHYMAL STEM CELLS FOR COMBINATION CHEMO AND IMMUNOTHERAPY OF OVARIAN CANCER". $100,000 OVER ONE YEAR.VIJI SHRIDHAR, PH.D. OF THE MAYO CLINIC "TARGETING LRRC15 TO INHIBIT METASTASIS AND RECURRENCE OF OVARIAN CANCER". $200,000 OVER TWO YEARSBRUCE WALCHECK, PH.D. OF THE UNIVERSITY OF MINNESOTA "ENGINEERED NATURAL KILLER CELLS EXPRESSING CHIMERIC CD64 AS A CANCER IMMUNOTHERAPY". $100,000 OVER ONE YEAR.NATIONAL EARLY DETECTION RESEARCH AWARDSROBERT BAST, M.D. OF M.D. ANDERSON "SERUM AUTOANTIBODIES FOR DETECTION OF EARLY STAGE OVARIAN CANCER" $50,000 FOR ONE YEAR.HAIWEI GU, PH.D. OF ARIZONA STATE UNIVERSITY "METABOLOMICS DIAGNOSIS OF OVARIAN CANCER". $50,000 OVER ONE YEAR.
Interesting data from their 2019 990 filing
The purpose of the non-profit, as set forth in the filing, is “The minnesota ovarian cancer alliance is dedicated to raising awareness and providing education and support to women and families impacted by ovarian cancer and advancing the research needed to detect the disease early and treat it effectively.”.
When discussing its purpose, they were characterized as: “Raise awareness, fund research, educate and support women and families impacted by ovarian cancer.”.
- The state in which the non-profit is legally authorized to operate is MN, as reported.
- The filing confirms that the non-profit's address in 2019 was 4604 CHICAGO AVENUE, MINNEAPOLIS, MN, 55407.
- The form of the non-profit reports 10 employees as of 2019.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is -$181,827.
- The organization has 13 independent voting members.
- The organization was formed in 1999.
- The organization pays $484,121 in salary, compensation, and benefits to its employees.
- The organization pays $64,238 in fundraising expenses.